107 related articles for article (PubMed ID: 29196029)
21. Detection of photoreactivity demonstrated in a modified local lymph node assay in mice.
Vohr HW; Homey B; Schuppe HC; Kind P
Photodermatol Photoimmunol Photomed; 1994 Apr; 10(2):57-64. PubMed ID: 8043386
[TBL] [Abstract][Full Text] [Related]
22. Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation.
Yabe K; Goto K; Jindo T; Sekiguchi M; Furuhama K
Toxicol Lett; 2005 Jul; 157(3):203-10. PubMed ID: 15917145
[TBL] [Abstract][Full Text] [Related]
23. Melanocyte melanin augments sparfloxacin-induced phototoxicity.
Hamanaka H; Mizutani H; Asahig K; Shimizu M
J Dermatol Sci; 1999 Sep; 21(1):27-33. PubMed ID: 10468189
[TBL] [Abstract][Full Text] [Related]
24. Reliability of phototoxic tests of fluoroquinolones in vitro.
Zhang T; Li JL; Ma XC; Xin J; Tu ZH
Acta Pharmacol Sin; 2003 May; 24(5):453-9. PubMed ID: 12740182
[TBL] [Abstract][Full Text] [Related]
25. A new photosafety screening strategy based on in chemico photoreactivity and in vitro skin exposure for dermally-applied chemicals.
Iyama Y; Sato H; Seto Y; Onoue S
Toxicol Lett; 2019 Dec; 317():45-52. PubMed ID: 31557510
[TBL] [Abstract][Full Text] [Related]
26. Miniature swine model of phototoxicity testing.
Leigh H; Forbes PD; Lawson C; Kim DY; White D; Brown LD; Wehmeier DR; Liu J; Bouchard GF
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):34-41. PubMed ID: 22212001
[TBL] [Abstract][Full Text] [Related]
27. Photosafety screening of phenothiazine derivatives with combined use of photochemical and cassette-dosing pharmacokinetic data.
Onoue S; Kato M; Inoue R; Seto Y; Yamada S
Toxicol Sci; 2014 Feb; 137(2):469-77. PubMed ID: 24241722
[TBL] [Abstract][Full Text] [Related]
28. Use of the yeast Saccharomyces cerevisiae as a pre-screening approach for assessment of chemical-induced phototoxicity.
Marrot L; Labarussiat A; Perez P; Meunier JR
Toxicol In Vitro; 2006 Sep; 20(6):1040-50. PubMed ID: 16497474
[TBL] [Abstract][Full Text] [Related]
29. Melanin protects choroidal blood vessels against light toxicity.
Peters S; Lamah T; Kokkinou D; Bartz-Schmidt KU; Schraermeyer U
Z Naturforsch C J Biosci; 2006; 61(5-6):427-33. PubMed ID: 16869503
[TBL] [Abstract][Full Text] [Related]
30. Evidence against melanin as the mediator of retinal phototoxicity by short-wavelength light.
Rapp LM; Smith SC
Exp Eye Res; 1992 Jan; 54(1):55-62. PubMed ID: 1541341
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of skin phototoxicity with three drugs by an in vivo mouse model.
Matsumoto N; Akimoto A; Kawashima H; Kim S
J Toxicol Sci; 2010 Feb; 35(1):97-100. PubMed ID: 20118629
[TBL] [Abstract][Full Text] [Related]
32. Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice.
Shimoda K; Yoshida M; Wagai N; Takayama S; Kato M
Toxicol Pathol; 1993; 21(6):554-61. PubMed ID: 8052802
[TBL] [Abstract][Full Text] [Related]
33. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
Neumann NJ; Grosse OJ; Ruzicka T; Lehmann P
Skin Pharmacol Appl Skin Physiol; 2001; 14(4):210-6. PubMed ID: 11464103
[TBL] [Abstract][Full Text] [Related]
34. Photo-chemically induced DNA effects in the comet assay with epidermal cells of SKH-1 mice after a single oral administration of different fluoroquinolones and 8-methoxypsoralen in combination with exposure to UVA.
Wirnitzer U; Gross-Tholl N; Herbold B; von Keutz E
Mutat Res; 2006 Oct; 609(1):1-10. PubMed ID: 16824784
[TBL] [Abstract][Full Text] [Related]
35. Melanin Pigmentation in Rat Eyes: In Vivo Imaging by Polarization-Sensitive Optical Coherence Tomography and Comparison to Histology.
Baumann B; Schirmer J; Rauscher S; Fialová S; Glösmann M; Augustin M; Pircher M; Gröger M; Hitzenberger CK
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7462-72. PubMed ID: 26595606
[TBL] [Abstract][Full Text] [Related]
36. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
Bech-Thomsen N; Angelo HR; Wulf HC
Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
[TBL] [Abstract][Full Text] [Related]
37. Integrated preclinical photosafety testing strategy for systemically applied pharmaceuticals.
Schümann J; Boudon S; Ulrich P; Loll N; Garcia D; Schaffner R; Streich J; Kittel B; Bauer D
Toxicol Sci; 2014 May; 139(1):245-56. PubMed ID: 24519524
[TBL] [Abstract][Full Text] [Related]
38. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Al-Ismail D; Edwards C; Anstey AV
Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
[TBL] [Abstract][Full Text] [Related]
39. Lack of phototoxicity potential with delafloxacin in healthy male and female subjects: comparison to lomefloxacin.
Dawe RS; Ferguson J; Ibbotson S; Lawrence L; Paulson S; Duffy E; Cammarata S
Photochem Photobiol Sci; 2018 Jun; 17(6):773-780. PubMed ID: 29721574
[TBL] [Abstract][Full Text] [Related]
40. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]